U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BRII-196
Preferred Name English
AMUBARVIMAB
INN  
Official Name English
BRII196
Code English
amubarvimab [INN]
Common Name English
AMUBARVIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
Amubarvimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA,ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) (SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-447) (VH(HOMO SAPIENS (IGHV3-66*01 (96%)-(IGHD)-IGHJ6*01
Common Name English
Code System Code Type Description
USAN
JK-255
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
INN
11988
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
NCI_THESAURUS
C175227
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
FDA UNII
2AD5KH3SE4
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
SMS_ID
300000026354
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
CAS
2509447-07-6
Created by admin on Wed Apr 02 09:13:09 GMT 2025 , Edited by admin on Wed Apr 02 09:13:09 GMT 2025
PRIMARY
ACTIVE MOIETY
AMUBARVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966